TSHA Collar Strategy
TSHA (Taysha Gene Therapies, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.
TSHA (Taysha Gene Therapies, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.67B, a beta of 1.23 versus the broader market, a 52-week range of 2.25-7.3, average daily share volume of 2.8M, a public-listing history dating back to 2020, approximately 73 full-time employees. These structural characteristics shape how TSHA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.23 places TSHA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a collar on TSHA?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current TSHA snapshot
As of May 15, 2026, spot at $5.95, ATM IV 102.70%, IV rank 14.02%, expected move 29.44%. The collar on TSHA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on TSHA specifically: IV regime affects collar pricing on both sides; compressed TSHA IV at 102.70% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 29.44% (roughly $1.75 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TSHA expiries trade a higher absolute premium for lower per-day decay. Position sizing on TSHA should anchor to the underlying notional of $5.95 per share and to the trader's directional view on TSHA stock.
TSHA collar setup
The TSHA collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TSHA near $5.95, the first option leg uses a $6.25 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TSHA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TSHA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $5.95 | long |
| Sell 1 | Call | $6.25 | N/A |
| Buy 1 | Put | $5.65 | N/A |
TSHA collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
TSHA collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on TSHA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on TSHA
Collars on TSHA hedge an existing long TSHA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
TSHA thesis for this collar
The market-implied 1-standard-deviation range for TSHA extends from approximately $4.20 on the downside to $7.70 on the upside. A TSHA collar hedges an existing long TSHA position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current TSHA IV rank near 14.02% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TSHA at 102.70%. As a Healthcare name, TSHA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TSHA-specific events.
TSHA collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TSHA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TSHA alongside the broader basket even when TSHA-specific fundamentals are unchanged. Always rebuild the position from current TSHA chain quotes before placing a trade.
Frequently asked questions
- What is a collar on TSHA?
- A collar on TSHA is the collar strategy applied to TSHA (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With TSHA stock trading near $5.95, the strikes shown on this page are snapped to the nearest listed TSHA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TSHA collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the TSHA collar priced from the end-of-day chain at a 30-day expiry (ATM IV 102.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TSHA collar?
- The breakeven for the TSHA collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TSHA market-implied 1-standard-deviation expected move is approximately 29.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on TSHA?
- Collars on TSHA hedge an existing long TSHA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current TSHA implied volatility affect this collar?
- TSHA ATM IV is at 102.70% with IV rank near 14.02%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.